Abstract

Glioblastoma is one of the most aggressive brain cancers. Chemotherapy is a standard modality for its therapy. Here, we demonstrated a novel strategy using a helium gas discharge tube as a tunable electromagnetic emission source to sensitize glioblastoma cells to the cytotoxicity of temozolomide (TMZ), a widely used drug for glioblastoma. After a single 7-min of treatment, the efficacy of TMZ was enhanced in two typical glioblastoma cell lines U87MG and A172 without affecting a normal human astrocyte cell line hTERT/E6/E7. The discharge tube is a non-invasive approach, which provides a safe, controllable, stable, and low-cost modality to improve the conventional chemotherapy.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call